期刊文献+

ENDOD1在前列腺癌组织及细胞中的表达及意义 被引量:2

Value of endonuclease domain containing 1 in progression of prostate cancer
下载PDF
导出
摘要 目的:观察比较核酸内切酶结构域内含蛋白1(endonuclease domain containing1,ENDOD1)在良性前列腺增生和前列腺癌组织中的表达差异;筛选存在ENDOD1特异性低表达的前列腺癌细胞系,继而通过调控该细胞ENDOD1蛋白表达,研究其在前列腺癌细胞中的生物学功能,初步探索ENDOD1基因与前列腺癌发生、进展的联系。方法:利用免疫组化SP法检测20例良性前列腺增生和21例前列腺癌术后标本组织中ENDOD1表达情况;利用RT-qPCR和Western blot方法观察ENDOD1的mRNA和蛋白在前列腺正常上皮细胞和不同类型前列腺癌细胞中的表达差异,筛选出特异性低表达细胞系;构建pCMV-N-Flag-ENDOD1重组质粒,转染前列腺癌细胞株,过表达ENDOD1蛋白,通过MTT法测定调控前后前列腺癌细胞活力的变化,流式细胞术检测细胞周期和凋亡,Transwell实验评价肿瘤细胞迁移和侵袭能力的改变。结果:免疫组化评分的方差分析结果显示ENDOD1表达与前列腺癌Gleason评分呈负性关联;RT-qPCR和Western blot实验结果表明ENDOD1在雄激素非依赖性前列腺癌细胞系PC3和DU145中存在着特异性低表达(P<0.05)。同时,MTT实验显示,在DU145细胞中,过表达ENDOD1肿瘤细胞活力显著下降(P<0.05);而流式细胞术检测结果表明过表达ENDOD1能够使DU145细胞周期停滞在G_0/G_1期,但细胞凋亡率无明显差异。此外,在Transwell实验中,过表达ENDOD1的DU145细胞迁移和侵袭能力明显下降(P<0.05)。结论:ENDOD1在Gleason评分越高的前列腺癌中表达越低,同时在雄激素非依赖性前列腺癌细胞系存在着特异性低表达;而过表达ENDOD1能明显抑制雄激素非依赖性前列腺癌细胞的生长、迁移和侵袭能力。 AIM:To analyze the difference of endonuclease domain containing 1(ENDOD1) expression between benign prostatic hyperplasia(BPH) tissues and prostate cancer(PCa) tissues and to investigate the effect of ENDOD1 on the biological function of human prostate cancer cells.METHODS:The BPH samples(n = 20) and PCa samples(n =21) were processed and analyzed according to the instruction of immunohistochemical(IHC) staining.The mRNA and protein levels of ENDOD1 in the normal prostate epithelial cells and prostate cancer cells were evaluated by RTqPCR and Western blot,respectively.The recombinant plasmids pCMV-N-Flag-ENDOD1 was constructed and was transfected into the human prostate cancer cells.The proliferation,apoptosis,migration and invasion abilities of the prostate cancer cells were evaluated by MTT assay,flow cytometry,Transwell migration and Matrigel invasion assays,respectively.RESULTS:The analysis of variance of the immunoreactivity score showed that PCa tissues with high Gleason score displayed significantly lower ENDOD1 expression than that with low Gleason score and BPH(P 〈 0.05).The expression of ENDOD1 at mRNA and protein levels in PC3 cells and DU145 cells was significantly lower than that in the LNCap cells(P 〈0.05).The proliferation of DU145 transfected with ENDOD1 was inhibited.The flow cytometry indicated that ENDOD1 over-expression in the DU145 cells resulted in a notable increase in G0/G1 phase arrest(P 〈0.05),but the apoptotic rates showed no statistical difference.The results of Transwell assay showed that migration and invasion abilities of the cells were also inhibited after transfection with over-expressing ENDOD1 plasmid(P 〈0.05).CONCLUSION:The expression of ENDOD1 significantly decreased in prostate cancer with high Gleaon score.Meanwhile,the ENDOD1 is specifically down-regulated in androgen independent prostate cancer(AIPC) cell lines.Over-expression of ENDOD1 remarkably inhibits the proliferation,migration and invasion abilities of AIPC.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2017年第1期7-12,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.81402111) 广东省自然科学基金资助项目(No.2015A030313031) 广东省医学科研基金资助项目(No.A2016435)
关键词 前列腺肿瘤 核酸内切酶结构域内含蛋白1 肿瘤侵袭 Prostate cancer Endonuclease domain containing 1 Neoplasm invasion
  • 相关文献

参考文献4

二级参考文献31

  • 1方习武,夏术阶,唐孝达.雄激素受体在人类前列腺癌发展中的作用研究[J].中国病理生理杂志,2004,20(7):1275-1279. 被引量:5
  • 2赵耀瑞,徐勇,张殿举,畅继武,张淑敏,史启铎,孙光,韩瑞发,姚庆祥,马腾骧.血清PSA、PSAD和PSAT在前列腺穿刺活检中的意义[J].中华泌尿外科杂志,2005,26(9):622-625. 被引量:35
  • 3Pan Q, Bao LW, Teknos TN, et al. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inacti- vation of RhoA and RhoC GTPases in head and neck squamous cell curcinoma. Cancer Res, 2006, 66: 9379-9384.
  • 4Wu D, Foreman TL, Gregory CW, et al. Protein kinase cepsilon has the potential to advance the recurrence of human prostate canc- er. Cancer Res, 2002, 62: 2423-2429.
  • 5Cornford P, Evans J, Dodson A, et al. Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol, 1999, 154: 137-144.
  • 6Gorinl MA, Pan Q. Protein kinase Ce : an oncogene and emerging tumor biomarker. Mol Cancer, 2009, 8 : 1-9.
  • 7Greenlee RT, Murray T, Bolden S, et al. Cancer statistics,2000[J]. CA Cancer J Clin, 2000, 50(1): 7-33.
  • 8Igawa T, Lin FF, Lee MS, et al. Establishment and characterization of androgen - independent human prostate cancer LNCaP cell model[J]. Prostate, 2002, 50(4) :222 - 235.
  • 9Denis LJ, Griffiths K. Endocrine treatment in prostate cancer [J]. Semin Surg Oncol, 2000,18(1): 52-74.
  • 10Lu S, Tsai SY, Tsai MJ. Molecular mechanisms of androgen - independent growth of human prostate cancer LNCaP - AI cells[J]. Endocrinology, 1999, 140(11): 5054-5059.

共引文献359

同被引文献12

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部